LoginSign Up
My AccountLogout
Smart Today

Search results for "You "

Choi Young-woo, CEO of SOOP,

Choi Young-woo, CEO of SOOP, "Pushing for Platform Integration, AI Advancement, and Strengthening Content Partnerships in the New Year"

|Smart Today=Reporter Kim Se-hyung| SOOP announced its business direction and key plans for 2026 at the '2025 Streamer...
김세형 기자 ·
Lee Chan-won, Model for Dong-A Pharmaceutical's Cold Medicine Panpyrin

Lee Chan-won, Model for Dong-A Pharmaceutical's Cold Medicine Panpyrin

|Smart Today=Reporter Kim Se-hyung| Dong-A Pharmaceutical (CEO Baek Sang-hwan) announced on the 27th that it has...
김세형 기자 ·
BTS 5th Album Release Announcement..

BTS 5th Album Release Announcement.."Filled with the Most BTS-like Music"

|Smart Today=Reporter Kim Se-hyung| HYBE officially announced the release of BTS's 5th studio album.
김세형 기자 ·
Daniel, Who Was Expelled from NewJeans, May Have to Pay 100 Billion Won to Adore

Daniel, Who Was Expelled from NewJeans, May Have to Pay 100 Billion Won to Adore

There are predictions that Daniel, who was expelled from the group NewJeans, may have to compensate Adore with 100...
김세형 기자 ·
SOOP, Change is Urgent.. Stock Price Expected to Hover for the Time Being - Hanwha Investment

SOOP, Change is Urgent.. Stock Price Expected to Hover for the Time Being - Hanwha Investment

|Smart Today=Reporter Kim Se-hyung| Hanwha Investment & Securities stated on the 22nd that SOOP urgently needs change...
김세형 기자 ·
Year-End Financial Holding Subsidiary Personnel Changes Converge on 'Stability'

Year-End Financial Holding Subsidiary Personnel Changes Converge on 'Stability'

The common keyword for the year-end CEO appointments of financial holding subsidiaries has been gathered as 'stability.
강민주 기자 ·
Youngpoong·MBK Partners

Youngpoong·MBK Partners "Korea Zinc, Choi Yoon-bum Takes on High Risks to Secure Management Rights"

As Korea Zinc has resolved to construct a smelter in the United States in collaboration with the U. S.
김세형 기자 ·

Most Viewed

1

Lee Chan-won, Model for Dong-A Pharmaceutical's Cold Medicine Panpyrin

 2

Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion

 3

Samsung Electronics, Target Price of 200,000 Won Emerges.. Equivalent to 10 Million Won Before Stock Split

 4

Samsung Electronics Reports 20 Trillion Won Operating Profit in Q4, Exceeding Heightened Expectations

 5

KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year

Picks for You

Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion

Samsung Electronics, Target Price of 200,000 Won Emerges.. Equivalent to 10 Million Won Before Stock Split

KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year

Stock Market Receives the Energy of the Red Horse.. First Day Breaks 4300 for the First Time

Samba Signs 1.1 Trillion Won Pharmaceutical Production Contract with European Pharmaceutical Company.. Acquisition of Local Production Plant in the U.S.

Youngpoong·MBK Partners "Korea Zinc, Choi Yoon-bum Takes on High Risks to Secure Management Rights"

Photos & Videos

Lee Chan-won, Model for Dong-A Pharmaceutical's Cold Medicine Panpyrin

Lee Chan-won, Model for Dong-A Pharmaceutical's Cold Medicine Panpyrin
Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion

Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
Samsung Electronics, Target Price of 200,000 Won Emerges.. Equivalent to 10 Million Won Before Stock Split

Samsung Electronics, Target Price of 200,000 Won Emerges.. Equivalent to 10 Million Won Before Stock Split
Samsung Electronics Reports 20 Trillion Won Operating Profit in Q4, Exceeding Heightened Expectations

Samsung Electronics Reports 20 Trillion Won Operating Profit in Q4, Exceeding Heightened Expectations